Atai Life Net Income

ATAI
 Stock
  

USD 3.53  0.37  11.71%   

Atai Life Sciences fundamentals help investors to digest information that contributes to Atai Life's financial success or failures. It also enables traders to predict the movement of Atai Life Stock. The fundamental analysis module provides a way to measure Atai Life's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Atai Life stock.
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  

Atai Life Net Income Analysis

Atai Life's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Net Income 
 = 
(Rev + Gain) 
-  
(Exp + Loss) 
More About Net Income | All Equity Analysis

Current Atai Life Net Income

    
  (196.25 M)  
Most of Atai Life's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Atai Life Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Compare to competition

Based on the recorded statements, Atai Life Sciences reported net income of (196.25 Million). This is 157.5% lower than that of the Healthcare sector and significantly lower than that of the Biotechnology industry. The net income for all United States stocks is 134.37% higher than that of the company.

Atai Life Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Atai Life's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Atai Life could also be used in its relative valuation, which is a method of valuing Atai Life by comparing valuation metrics of similar companies.
Atai Life is currently under evaluation in net income category among related companies.

Atai Life Institutional Holders

Institutional Holdings refers to the ownership stake in Atai Life that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Atai Life's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Atai Life's value.
Security TypeSharesValue
Zurcher Kantonalbank Zurich CantonalbankCommon Shares22 K80 K
Xtx Topco LtdCommon Shares17.8 K136 K
Woodline Partners LpCommon Shares750 K2.7 M
Woodline Partners LpCommon Shares763.9 K3.9 M
Woodline Partners LpCommon Shares838 K6.4 M
Woodline Partners LpCommon Shares750 K11.1 M
Woodline Partners LpCommon Shares791.6 K14.6 M

Atai Life Fundamentals

About Atai Life Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Atai Life Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Atai Life using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Atai Life Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The companys therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment of treatment-resistant depression RL-007, a cholinergic, glutamatergic, and GABA-B receptor modulator to treat cognitive impairment associated with schizophrenia DMX-1002, an oral formulation of ibogaine for treating opioid use disorder GRX-917, an oral formulation of a deuterated version of etifoxine for the generalized anxiety disorder treatment and NN-101, a novel intranasal formulation of N-acetylcysteine to treat mild traumatic brain injuries. Its therapeutic candidates also comprise VLS-01, a formulation of N,N-dimethyltryptamine for treating TRD EMP-01, an oral formulation of an 3,4-methyl enedioxy methamphetamine for the treatment of post-traumatic stress disorder RLS-01, a formulation of Salvinorin A for TRD KUR-101, an oral formulation of deuterated mitragynine to treat OUD and DMX-1001, an oral formulation of noribogaine for the treatment of OUD. The company was formerly known as Adripa Holding B.V. Atai Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany.

Atai Life Investors Sentiment

The influence of Atai Life's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Atai Life. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.
Investor biases related to Atai Life's public news can be used to forecast risks associated with investment in Atai Life. The trend in average sentiment can be used to explain how an investor holding Atai Life can time the market purely based on public headlines and social activities around Atai Life Sciences. Please note that most equiteis that are difficult to arbitrage are affected by market sentiment the most.
Atai Life's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Atai Life's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Atai Life's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Atai Life.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atai Life in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atai Life's short interest history, or implied volatility extrapolated from Atai Life options trading.

Pair Trading with Atai Life

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atai Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atai Life will appreciate offsetting losses from the drop in the long position's value.

Moving against Atai Life

-0.67NFLXNetflix TrendingPairCorr
The ability to find closely correlated positions to Atai Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atai Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atai Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atai Life Sciences to buy it.
The correlation of Atai Life is a statistical measure of how it moves in relation to other equities. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atai Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atai Life Sciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atai Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Please continue to Atai Life Piotroski F Score and Atai Life Altman Z Score analysis. Note that the Atai Life Sciences information on this page should be used as a complementary analysis to other Atai Life's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for Atai Life Stock analysis

When running Atai Life Sciences price analysis, check to measure Atai Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atai Life is operating at the current time. Most of Atai Life's value examination focuses on studying past and present price action to predict the probability of Atai Life's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Atai Life's price. Additionally, you may evaluate how the addition of Atai Life to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Is Atai Life's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Atai Life. If investors know Atai Life will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Atai Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
(0.97) 
Market Capitalization
524.2 M
Quarterly Revenue Growth YOY
(0.91) 
Return On Assets
(0.22) 
Return On Equity
(0.54) 
The market value of Atai Life Sciences is measured differently than its book value, which is the value of Atai Life that is recorded on the company's balance sheet. Investors also form their own opinion of Atai Life's value that differs from its market value or its book value, called intrinsic value, which is Atai Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Atai Life's market value can be influenced by many factors that don't directly affect Atai Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Atai Life's value and its price as these two are different measures arrived at by different means. Investors typically determine Atai Life value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Atai Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.